Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Поисковый запрос: (<.>S=ВЫСОКИЕ ДОЗЫ<.>)
Общее количество найденных документов : 1697
Показаны документы с 1 по 20
 1-20    21-40   41-60   61-80   81-100   101-120      
1.
Regression of Kaposi's sarcoma after intravenous immunoglobulin treatment for polymyositis // Cancer, 1994. Vol. 73, N 11.-С.2859-2861

2.
Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed disease // Cancer, 1994. Vol. 74, N 2.-С.715-721

3.
Konitzer M. Hochdosierte Viscum album Gaben bei malignen Tumoren des ZNS // Dtsch. Z. Onkol., 1992. Vol. 24, N 6.-С.152-154

4.
Double-cycle high-dose chemotherapy with peripheral blood stem cells and hematopoietic growth factor support in patients with advanced solid tumor: A Pilot Study by the Hong Kong Biotherapy Group // Cancer, 1994. Vol. 73, N 7.-С.1960-1970

5.
Phase I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: а cancer and leukemia group B study // J. Nat. Cancer. Inst., 1993. Vol. 85, N 16.-С.1319-1326

6.
Successful peripheral blood stem cell harvest (PRSCH) with high dose cyclophosphamide and GM-CSF prior to PBSCT in relapsed and refractory myeloma // Brit. J. Haematol., 1994. Vol. 86, Suppl. N1.-С.77

7.
Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies // Bone Marrow Transpalnt, 1994. Vol. 14, N 1.-С.105-111

8.
Granulocyte-macrophage colony-stimulating factor given before dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) // Biotechnol. Ther., 1993. Vol. 4, N 3-4.-С.183-195

9.
Borowitz D. Safety of long-term ranitidine in patients with cystic fibrosis // Pediat. Pulmonol., 1993, Suppl. N9.-С.275

10.
Effects of high-dose intracoronary irradiation on vasomotor function and smooth muscle histopathology // Amer. J. Physiol., 1994. Vol. 267, N 1.-С.Н125-Н132

11.
Phenotypic differences of CD34 - positive stem cells harvested from peripheral blood and bone marrow obtained before and after peripheral blood stem cell collection // Bone Marrow Transplant., 1994. Vol. 13, N 5.-С.527-532

12.
High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia // Bone Marrow Transplant., 1994. Vol. 14, N 1.-С.57-61

13.
High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer // Cancer, 1994. Vol. 73, N 7.-С.1842-1848

14.
High-dose chemotherapy (VIC) and bone marrow support in advanced sarcomas // Bone Marrow Transplant., 1994. Vol. 14, Suppl. N1.-С.55

15.
Optimal blood stem cell mobiliration using 10 'мю'/ granulocyte colony-stimuating factor (G-CSF) lone for high-dose melphalan inbensitication in multiple myeloma: an intrapatient controlled study // Amer. J. Hematol., 1994. Vol. 47, N 2.-С.135-138

16.
Miser James S. High-dose chemotherapy and systemic adjuvant irradiation in Ewing's sarcoma // Bone Marrow Transplant., 1994. Vol. 14, Suppl. N1.-С.54

17.
Timed-sequential high-dose cyclophosphamide and vincristine in the treatment of multiple myeloma // Cancer, 1994. Vol. 73, N 8.-С.2113-2118

18.
Livingston Robert B. Dose intensity and high dose therapy. Two different concepts // Cancer, 1994. Vol. 74, N 3 Suppl..-С.1177-1183

19.
Prevention of hemorrhagic cystitis after high-dose alkylating agent chemotherapy and autologous bone marrow support // Bone Marrow Transplant., 1994. Vol. 14, N 2.-С.287-291

20.
Double blind placebo controlled randomized study of highdose immunoglobuline 7S: Therapy in multiple sclerosis // Schweiz. Arch. Neurol. und Psychiat., 1993. Vol. 144, N 4.-С.362-363

 1-20    21-40   41-60   61-80   81-100   101-120      
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)